SPY424.31+0.70 0.17%
DIA345.12+0.14 0.04%
IXIC14,069.42+49.09 0.35%

Compugen Expands Research Collaboration with Johns Hopkins University for Novel Tumor Growth Inhibitor

05/10/2021 04:43

08:30 AM EDT, 05/10/2021 (MT Newswires) -- Compugen (CGEN), a clinical-stage cancer immunotherapy company, said Monday it expanded its research collaboration with Johns Hopkins University to focus on a new myeloid target that was discovered by the company.

Initial preclinical studies demonstrate the potential of this target to inhibit tumor growth.

The expanded research plans to further explore the role of the target in various tumors, the company said in a Monday news release.

Price: 7.68, Change: +0.09, Percent Change: +1.25